IVA News
Archived Headlines
- French NASH biotech Inventiva sets terms for $102 million US IPO 07/06/20
- US IPO Week Ahead: Third quarter kicks off with China’s largest gay dating app 07/02/20
- US IPO Weekly Recap: Royalty Pharma takes the crown in 5 IPO week 06/19/20
- French NASH biotech Inventiva files for a $90 million US IPO 06/19/20
US IPO Week Ahead: The IPO market cools off in a 7 IPO week
Updated Monday, 10/5. Following an active September, seven IPOs and four SPACs are scheduled to raise $2.3 billion in the week ahead. Live TV streaming platform fuboTV (FUBO) plans to raise $150 million at a $1.4 billion...read more
US IPO Weekly Recap: Preclinical biotech Nkarta pops 166% in a 5 IPO week
Three biotechs, two Chinese issuers, and one SPAC went public this past week, led by preclinical oncology biotech Nkarta (NKTX), which popped 166% in the best first-day return for a $10+ million IPO since 2015. Some major news hit the IPO...read more
French NASH biotech Inventiva prices US IPO at $14.40 midpoint
Inventiva, a Phase 2 French biotech developing therapies for NASH and other diseases, raised $108 million by offering 7.5 million ADSs at $14.40, the midpoint of the revised range of $13.40 to $15.40. The company originally planned to offer the same number of...read more
French NASH biotech Inventiva increases range ahead of $108 million US IPO
Inventiva, a Phase 2 French biotech developing therapies for NASH and other diseases, raised the proposed range for its upcoming IPO on Wednesday. The Daix, France-based company now plans to raise $108 million by offering 7.5 million ADSs at a price range...read more